Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,063B 11.25B 9.69B 8.93B 8.38B 15.73B 15.9B 105B 41.09B 521B 42.21B 41.31B 1,805B P/E Ratio 2027 *
24.3x
P/E Ratio 2028 * 19.9x
Enterprise Value 1,026B 10.85B 9.35B 8.61B 8.09B 15.18B 15.35B 102B 39.65B 503B 40.74B 39.87B 1,742B EV / Sales 2027 *
2.87x
EV / Sales 2028 * 2.55x
Free-Float
70.07%
Yield 2027 *
0.6%
Yield 2028 * 0.64%
1 day-0.97%
1 week-0.56%
Current month-2.94%
1 month-5.01%
3 months-1.44%
6 months-0.58%
Current year-0.50%
1 week 1,261.7
Extreme 1261.7
1,298.6
1 month 1,248
Extreme 1248
1,347.1
Current year 1,149
Extreme 1149
1,376
1 year 1,149
Extreme 1149
1,376
3 years 972.85
Extreme 972.85
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 2019-06-30
Director of Finance/CFO - -
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 2014-05-12
Chairman 65 2013-04-01
Director/Board Member 65 2018-10-24
Date Insider Type Main position Quantity % Market Cap.
03-31Other

Global Head of Quality and PV

35,600 0.0043%
12-17Other

Director

27,618,385 3.3092%
12-17Other

Executive/Senior Manager

75,624 0.0091%
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%-0.56%-4.12%+29.75% 11.25B
-0.61%-1.94%+39.00%+150.72% 1,001B
-0.20%-0.77%+51.51%+43.20% 566B
+0.40%-1.31%+16.56%+60.47% 393B
-0.28%+2.29%+24.04%+16.53% 326B
-0.28%+0.55%+25.25%+31.76% 276B
-0.08%-1.19%+24.78%+14.24% 277B
+1.73%+1.11%-41.34%-47.13% 193B
-0.77%+0.95%+17.69%+51.46% 188B
+2.36%+1.38%+14.80%+61.34% 158B
Average +0.13%+0.38%+16.82%+41.23% 338.81B
Weighted average by Cap. -0.06%-0.40%+27.75%+67.23%

Financials

2027 *2028 *
Net sales 357B 3.78B 3.25B 3B 2.81B 5.28B 5.34B 35.41B 13.79B 175B 14.17B 13.87B 606B 394B 4.17B 3.59B 3.31B 3.1B 5.83B 5.89B 39.06B 15.22B 193B 15.63B 15.3B 668B
Net income 44.07B 466M 402M 370M 347M 652M 659M 4.37B 1.7B 21.58B 1.75B 1.71B 74.79B 54.05B 572M 493M 454M 426M 800M 808M 5.36B 2.09B 26.47B 2.15B 2.1B 91.72B
Net Debt -37.13B -393M -338M -312M -293M -549M -555M -3.68B -1.43B -18.18B -1.47B -1.44B -63B -59.51B -629M -542M -500M -469M -881M -890M -5.9B -2.3B -29.14B -2.36B -2.31B -101B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
26-06-17 1,264.20 -1.01% 20,961
26-06-16 1,277.05 -0.17% 13,363
26-06-15 1,279.25 +0.42% 37,483
26-06-12 1,273.90 -0.09% 16,559
26-06-11 1,275.05 +0.26% 36,735
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,277.05INR
Average target price
1,331.77INR
Spread / Average Target
+4.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!